Cite
HARVARD Citation
Ravichandran, S. et al. (2021). Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real‐world longitudinal data. British journal of haematology. pp. 587-597. [Online].